Singapore, March 10 -- Pfizer Japan Inc., and ASKA Pharmaceutical have announced that they will begin co-promotion of the Respiratory Syncytial Virus (RSV) vaccine "ABRYSVO(R) intramuscular injection", in Japan starting April 1, 2026.

Published by HT Digital Content Services with permission from BioSpectrum Asia....